YOUR BUSINESS AUTHORITY

Springfield, MO

Home
Digital Edition
Events
Industries
Opinion
Podcasts
Photo Galleries
News Features
Sponsored Content

Log in Subscribe

Sanofi to buy Kymab for $1.1B

Posted online January 11, 2021 | 7:58 am

French pharmaceutical company Sanofi SA signed on to purchase United Kingdom-based Kymab for $1.1 billion.

The acquisition of the biopharmaceutical company also includes payments of up to $350 million upon the achievement of certain milestones.

Kymab focuses on developing fully human monoclonal antibodies.

Read more from MarketWatch.

Comments

No comments on this story |

Please log in to add your comment

More from SBJ Daily Update

Springfield looks to define ‘data center’ and extend administrative delay on their development

Editors' Pick

Springfield pair angles for success with Hook IQ fishing app

Innovation provides intel for optimal results at any waterway.

Most Read

Clothing store closing Branson location

Nine show interest in four Springfield City Council seats

Jack Henry executive compensation rises

Owl sculpture unveiled in Rountree park

Banker pleads guilty to fraud scheme

Disney licenses several titles to Netflix

MSU marks momentum after first year of strategic plan

SBJ.net Poll

Springfield's jobless rate ticked down from July to August, according to the latest federal data. Is your firm expanding its workforce?

*

Update cookies preferences